|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.96(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,004,919 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Steward Randall J |
Chief Financial Officer |
|
2017-12-12 |
4 |
OE |
$22.21 |
$808,066 |
D/D |
36,383 |
56,290 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-12-08 |
4 |
S |
$40.41 |
$661,529 |
D/D |
(16,358) |
3,718 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-12-08 |
4 |
OE |
$23.41 |
$382,941 |
D/D |
16,358 |
12,976 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-12-05 |
4 |
S |
$40.51 |
$548,343 |
D/D |
(13,536) |
3,718 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-12-05 |
4 |
OE |
$22.85 |
$309,991 |
D/D |
13,536 |
4,956 |
|
- |
|
Brown Thomas D |
Director |
|
2017-12-05 |
4 |
S |
$39.62 |
$481,541 |
D/D |
(12,154) |
45,025 |
|
- |
|
Brown Thomas D |
Director |
|
2017-12-05 |
4 |
OE |
$16.25 |
$197,503 |
D/D |
12,154 |
57,179 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2017-12-04 |
4 |
S |
$40.05 |
$992,479 |
D/D |
(24,781) |
7,642 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2017-12-04 |
4 |
OE |
$12.63 |
$353,669 |
D/D |
24,781 |
20,254 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-30 |
4 |
S |
$37.84 |
$454,080 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-30 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-29 |
4 |
S |
$37.53 |
$450,360 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-29 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-28 |
4 |
S |
$36.72 |
$440,640 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-11-28 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2017-11-09 |
4 |
S |
$38.90 |
$309,907 |
D/D |
(7,965) |
7,642 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-11-06 |
4 |
S |
$39.50 |
$298,818 |
D/D |
(7,565) |
3,718 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2017-11-06 |
4 |
OE |
$22.85 |
$172,860 |
D/D |
7,565 |
10,261 |
|
- |
|
Widder Kenneth J |
Director |
|
2017-11-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
530 |
5,680 |
|
- |
|
Buechler Kenneth F |
Director |
|
2017-11-03 |
4 |
OE |
$19.48 |
$90,874 |
D/D |
4,665 |
27,083 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-10-31 |
4 |
S |
$41.21 |
$494,472 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-10-31 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-10-30 |
4 |
S |
$41.15 |
$493,800 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-10-30 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-10-27 |
4 |
S |
$42.29 |
$507,480 |
D/D |
(12,000) |
284,493 |
|
- |
|
1127 Records found
|
|
Page 23 of 46 |
|
|